(Q42818168)

7 November 2017

title

Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations (English)

1 reference

7 November 2017

1 reference

C Q Cai

1

1 reference

7 November 2017

Y Peng

2

1 reference

7 November 2017

M T Buckley

3

1 reference

7 November 2017

J Wei

4

1 reference

7 November 2017

F Chen

5

1 reference

7 November 2017

L Liebes

6

1 reference

7 November 2017

W L Gerald

7

1 reference

7 November 2017

M R Pincus

8

1 reference

7 November 2017

I Osman

9

1 reference

7 November 2017

P Lee

10

1 reference

7 November 2017

language of work or name

English

0 references

publication date

14 January 2008

1 reference

7 November 2017

1 reference

7 November 2017

volume

27

1 reference

7 November 2017

issue

22

1 reference

7 November 2017

page(s)

3201-3210

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210983

7 November 2017

exact match

0 references

cites work

EGF receptor mutations in lung cancer: from humans to mice and maybe back to humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

EGF-independent activation of cell-surface EGF receptors harboring mutations found in gefitinib-sensitive lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Expression of complete keratin filaments in mouse L cells augments cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

EGF-ERBB signalling: towards the systems level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Novel mutations of epidermal growth factor receptor in localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Interleukin-6 is an autocrine growth factor in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Epidermal growth factor receptor: mechanisms of activation and signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Somatic mutations of epidermal growth factor receptor in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

ErbB receptors: possible therapeutic targets in prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

A matrix metalloproteinase expressed on the surface of invasive tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

inferred from DOI database lookup

7 January 2021

based on heuristic

EGF receptor inhibition: Attacks on multiple fronts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210983

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1210983

1 reference

Dimensions Publication ID

7 November 2017

1051783289

0 references

1 reference